Considering the impact of obesity on diabetes, along with weight gain that generally accompanies the use of insulin, insulin secretagogues, and insulin sensitizers, interventions with favorable effects on weight are likely to become increasingly important. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.